West Pharmaceutical Services

Newswire/News Agency
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2018 sales of $1.7 billion reflect the daily use of approximately 112 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world. Source

Actions

Share this page

Media Outlet details

Scope International, Consumer
Language French
Country United States of America
Similarweb UVMSimilarweb UVM Request pricing
Comscore UVMComscore UVM Request pricing

Recent Articles

Search

Beyond the Container: Materials and Technical Challenges in Parenteral Packaging

| West Pharmaceutical Services
In parenteral packaging, compatibility is often one of the first considerations evaluated during development. However, compatibility alone does not guarantee success. A component may demonstrate acceptable compatibility with a drug formulation yet still introduce challenges if it cannot consistently support manufacturing, assembly, storage, transportation, and administration. When a packaging related challenge arises, the root cause is not always the primary container itself.
Open in Who Shared Issue with article?

Syringe Performance and Drug Containment Risk: Why Plunger Performance Matters in Prefilled Syringes

| West Pharmaceutical Services
As the use of pre‑filled syringes (PFS) and self‑administration devices continues to grow, syringe performance has become a critical factor in managing drug containment risk across the product lifecycle. While elastomer components may be designed and manufactured to high quality standards, they must also perform reliably within the syringe system—from fill/finish and storage, through global distribution, to final administration by the patient.
Open in Who Shared Issue with article?

Considerations in Design and Development of Novel Combination Drug-Delivery Devices

| West Pharmaceutical Services
Developing a novel (as opposed to utilizing a platform technology) drug delivery device is a complex, and highly iterative endeavor. There are several considerations to keep in mind, and West will be publishing a series of blog posts to detail those considerations; the first post in the series will focus on how to successfully land on the right problem definition and ensure appropriate scoping as that’ll have a significant impact on timelines, program cost, and realization of outcomes.
Open in Who Shared Issue with article?

Annex 1 – The West Perspective​

| West Pharmaceutical Services
This product is not clubbable with other items in cart. Please remove this or other items to proceed further. This product is not clubbable with other items in cart. Please remove this or other items to proceed further. Products from multiple soldto's are in cart. Only products from single soldto is allowed in cart. Checkout Proceed To Loa Form Checkout
Open in Who Shared Issue with article?

Transitioning to ISO 80369‑7: Enhancing Safety and Performance in Vial Adapter™ Transfer Devices

| West Pharmaceutical Services
Smarter, Safer, Needle-Free Drug Transfer with West’s Vial Adapter™ Transfer Device Vial adapter™ transfer devices are needle-free solutions designed to simplify the reconstitution and transfer of drug products. They provide a safe and efficient way to prepare injectable medications while helping reduce the risk of needlestick injuries and particulate contamination [1].
Open in Who Shared Issue with article?

Ophthalmic Drug Delivery: Meeting Modern Challenges with a Next‑Generation Solution

| West Pharmaceutical Services
With every ophthalmic injection comes the responsibility of protecting vision, ensuring patient comfort, and safeguarding drug quality.
Open in Who Shared Issue with article?

West E&L Day: Navigating the Evolving Extractables and Leachables Landscape

| West Pharmaceutical Services
Join us for this in-person educational event focused on Extractables & Leachables (E&L) activities. We will explore topics such as packaging, manufacturing, related toxicological assessments, and updates to pertinent guidelines. Subject matter experts from West, along with external experts in toxicology and drug manufacturing processes, will share insights and perspectives on current E&L challenges and emerging trends.
Open in Who Shared Issue with article?

Understanding the Shift from ISO 594 to ISO 80369: What Medical Device Manufacturers and Partners Need to Know

| West Pharmaceutical Services
In the world of medical devices, ensuring the safety and compatibility of equipment is fundamental to patient care. Among the most significant developments in this area is the replacement of ISO 594 by ISO 80369, a series of standards redefining how medical connectors are designed and validated. For decades, ISO 594 served as the reference for Luer connectors, the small fittings that link syringes, tubing, and catheters for fluid and gas delivery.
Open in Who Shared Issue with article?

Strengthening Community Impact: Bangalore GTC Advances Its Technology Giving Program

| West Pharmaceutical Services
Continuing our commitment to strengthening the communities where we live and work, the Bangalore GTC team recently completed another successful technology donation drive, providing refurbished laptops and other devices to schools with limited access to technology. This initiative reflects our dedication to sustainable development and demonstrates how our people can use what they do best to make a meaningful difference in empowering future generations.
Open in Who Shared Issue with article?

USP Revisions: What They Mean for Injectable Drug Quality and Why Packaging Matters More Than Ever

| West Pharmaceutical Services
Controlling particulate matter in injectable drug products has long been a cornerstone of patient safety. While large visible particles often gain public attention through recalls, subvisible particulate contamination the particles you can’t see pose an equally serious risk. These particles can compromise product quality, trigger inflammation or immune reactions, and jeopardize the safety of sensitive patient populations.
Open in Who Shared Issue with article?